WO2004026273A1 - 口腔用組成物 - Google Patents
口腔用組成物 Download PDFInfo
- Publication number
- WO2004026273A1 WO2004026273A1 PCT/JP2003/009427 JP0309427W WO2004026273A1 WO 2004026273 A1 WO2004026273 A1 WO 2004026273A1 JP 0309427 W JP0309427 W JP 0309427W WO 2004026273 A1 WO2004026273 A1 WO 2004026273A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- collagenase
- gingivalis
- bark
- pepper
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Definitions
- the present invention relates to oral compositions. More specifically, at least one rice field selected from the group consisting of banapa leaves, dohi bark, river rind bark, potato, feng ginseng, white pepper, black pepper, small jin, and wu li
- the present invention relates to a composition for oral cavity having an inhibitory effect on darcosyltransferase or an inhibitory effect on growth of Porphyromonas gingivalis bacteria, which comprises an extract of a seed.
- caries caries
- periodontal disease The two major diseases of the oral cavity, caries (caries) and periodontal disease, are both infectious diseases caused by pathogenic bacteria and are among the most prevalent diseases, regardless of gender or age.
- Caries is a phenomenon in which calcium phosphate, which accounts for about 97% of the tooth components, is dissolved (demineralized) by the acid produced by a series of oral streptococci commonly referred to as mutans streptococci.
- Periodontal disease is a pathological condition that originates in the periodontal tissue and impairs its function, and is an inflammatory disease caused by bacteria in the plaque (puller, periodontal disease.
- caries and periodontal disease progress as follows: First, caries is formed by oral bacteria such as mutans streptococci on the tooth surface layer. The enzymatic action of darcosyltransferase, produced by the mutans streptococci, produces a sticky polysaccharide (glucan) converted from sucrose in food on the tooth enamel surface. Then, based on this glucan, as various oral bacteria such as Streptococcus grow, the glucan gradually becomes insoluble, And the clumps of bacteria form a layer, forming plaque. On the other hand, when the pH of the tooth surface is reduced to 5.5 or less by the organic acid produced by the oral bacterial force, caries are generated and progress.
- oral bacteria such as mutans streptococci
- the oxygen in the plaque is consumed by the action of bacteria's active oxygen scavenging enzyme in the area closer to the teeth in the layer, and oxygen is reduced from oxygen-rich aerobic conditions. Migrated under less anaerobic conditions.
- obligate anaerobic bacteria which had not been able to grow before, will be able to proliferate, and the number of bacteria will increase.
- the plaque layer becomes thicker, and the plaque covers the periodontal pockets from the root. If this condition develops further, it will lead to periodontal disease and alveolar pyorrhea.
- Japanese Patent Application Laid-Open No. 57-58610 discloses a plant selected from Ryokan, Shinobi winter, Kuromoji, Minami Amami, Yamako, Peony, Kouji, Toshi, Almond, Momiji, Shiso and Kakiha An oral composition characterized by containing one or more of the following organic solvent extracts is disclosed. Japanese Patent Application Laid-Open No.
- 58-121218 discloses a caries preventive agent containing a crude drug extract having a GTase inhibitory activity as an essential component. , Fennel, peony, gentian, senso, white water, dragon bile, oren, sempuri and yellow sesame.
- Japanese Patent Application Laid-Open No. 4-99771 discloses a method for producing a carious pile and an anti-cariogenic substance using an aqueous solvent extract from sweet tea as an active ingredient.
- Japanese Patent Application Laid-Open No. Hei 4-221308 discloses that Darco comprising an extract obtained by extracting the aerial part of a plant belonging to the genus Ros with water, a hydrophilic organic solvent, butanol, or a mixture thereof.
- Syltransferase inhibitors have been disclosed.
- Japanese Patent Application Laid-Open No. Hei 4 (1996) -33853 discloses a caries preventive comprising a hydrophilic organic solvent extract of Ebisda. It has been disclosed.
- Japanese Unexamined Patent Publication No. 7-53398 discloses a darkosyltransferase which is characterized by containing an extract of Agrimony.
- Japanese Patent Application Laid-Open No. H11-152228 discloses a caries preventive comprising an extract of Salasia's reticulata overnight.
- periodontal disease is due to an increase in periodontopathogenic plaque bacteria, invasion of bacteria into tissues, and host response to infection. Especially Porphyromonas gingivalis
- P. gingivalis is a bacterium that is considered to be the most probable pathogen of adult periodontitis, which is considered to be the most common periodontal disease. Is frequently separated from the lower part of the periodontal pocket. This P. gingivalis produces collagenases and other proteolytic enzymes because the peptide is used as a growth source.
- This bacterium is a non-motile, gram-negative bacillus that forms black colonies on blood plates and produces proteinases such as collagenase, phospholipase A, alkaline phosphatase, and acid phosphatase. It has been known.
- collagenase is said to be a direct factor leading to gingival tissue destruction because it has an action of degrading periodontal tissue collagen.
- Early periodontal disease is triggered by an early immune response to antigens derived from plaque bacteria, ie, the production of chemotactic factors and pro-inflammatory cytokines such as TNF- ⁇ , IL-1, and IL-6.
- Site forces such as TN F— «and IL-11 induce the synthesis of collagenase, a kind of matrix smear proteases (MM P).
- P. gingivalis Human tissue-derived collagenase is a factor that promotes the progression of periodontal disease because it has the activity of degrading periodontal tissue. Therefore, in order to effectively prevent and treat periodontal disease, it is necessary to suppress the growth of P. gingivalis in periodontal pockets, suppress the degradation of collagen from gingival tissues, and increase the growth factors of P. gingivalis. Suppressing the collagenase activity can prevent periodontal disease. However, none of them has been sufficiently satisfactory.
- banana leaves, Dokhihi, Sengrenhi, Senryo, Fengsan (Kenzin), white pepper, black pepper, shoji, buoy at least one extracted extract selected from the group consisting of: At least one selected from the group consisting of an oral composition having an inhibitory action or a periodontal pathogen P. gingivalis growth inhibitory action, and banaba leaf, soil thorn bark, river bark, potato, and fir ginseng Darcosyltransferase inhibitor, or at least one extract selected from the group consisting of white pepper, black pepper, Xiaojin, and Wuyi.
- P. gingivalis growth inhibitor characterized by the following.
- the present inventors have derived from highly safe natural products, have excellent productivity, act against causative bacteria of caries, and have a strong effect on the darcosyltransferase produced by the causative bacteria. Because of its inhibitory activity, it has a strong inhibitory activity against periodontal disease bacteria and collagenase from human tissues as well as a potent growth inhibitory activity against periodontal disease bacteria P. gingivalis.
- Various studies were carried out for the purpose of finding an oral composition useful as a prophylactic agent for periodontal disease because of having the above.
- the contained oral composition is useful as a composition for preventing dental caries or preventing periodontal disease, and completed the present invention.
- the present invention relates to banaba leaves, dokeihi, senrenhi, senryo, potato, kenjin, white pepper, black pepper, shogei, and wuyi Buoy) containing at least one extract selected from the group consisting of darcosyltransferase inhibitory activity and periodontal pathogen Porphyromonas gingivalis growth inhibitory activity.
- the present invention relates to an oral composition having Further, it is preferable that the oral composition is the oral composition for preventing dental caries or periodontal disease.
- the above-mentioned darcosyltransferase inhibitor is preferably at least one extract selected from the group consisting of banaba leaf, earthen bark, river rind, potato, and ginseng.
- the growth inhibitor of Porphyromonas gingivalis which is a periodontal pathogen, is preferably at least one extract selected from the group consisting of white pepper, black pepper, small jelly, and Wuyi.
- the present invention also relates to a collagenase inhibitor comprising an extract of banaba leaf as an active ingredient.
- collagenase inhibitor is preferably derived from the periodontal pathogens Borphyromonas, Porphyromonas gingivalis or human fibroblasts.
- Ling rstro emi aspeciosa (L.) Pe rs.) Is a member of the family Sorrelidae and is a type of squirrel that is distributed in tropical Asia, also known as the squirrel, and its leaves and extracts. Has been used for a long time as a therapeutic drug.
- banaba leaf extract has been used in the Philippines since ancient times as a remedy for diabetes.
- the extract of banapa leaf has also attracted attention in Japan as a material for diet and diabetes.
- the thorn bark (Pseudo 1 ar X ka emp feri Gord.) Belongs to the family Pinaceae, and is also known as gold pine or pine larch, and its bark or root bark is dried. 2003/009427
- Both black pepper and white pepper belong to the genus Pepper in the family Pepper, and are also known as pepper and are also called pipernigrams.
- Black pepper is harvested before the fruits ripen and dried with the skin, and white pepper is dried without the rind of the ripe fruits. Both have been used as spices since ancient times, and their extracts have also been used as presentation improving agents.
- the sword (Ce pha l anop losseget um Kitam.) Belongs to the family Asteraceae and is also known as alethia thistle, and is also called field thistle, mountain thistle, sashimi, eyebrow crop, eyebrow brush, whole grass or The root is the medicated site.
- alethia thistle Belongs to the family Asteraceae and is also known as alethia thistle, and is also called field thistle, mountain thistle, sashimi, eyebrow crop, eyebrow brush, whole grass or The root is the medicated site.
- Wuyi Ulmus macrocarpa Hanse
- the banaba leaves, dorsal bark, river rind bark, potato, feng ginseng, white pepper, black pepper, small tom, and wu li used in the present invention include crude drugs, semi-dried and dried products. Dried products are preferred. These raw materials are preferably used after being ground. After the extract has been dried, it can be used in the form of a crushed powder, if necessary.
- the extract of banaba leaves, dorsal bark, turkey bark, turkey bark, potato, feng ginseng, white pepper, black pepper, small tortoise, and black liquor used in the present invention is obtained by extracting the above material group by the method exemplified below.
- the extract of the present invention The term includes not only dried products obtained by the above method, but also extracts, concentrated solutions, and diluted solutions before drying.
- the extraction method a commonly used method can be used, and is not particularly limited.
- a heating extraction (decoction) method is performed while heating and stirring, and a method is obtained by filtering to obtain an extract, or a percollation method.
- the heat extraction method is, for example, a method in which purified water is added to banaba leaves, and the extract is obtained by boiling and then heating for about 30 minutes.
- an extract of banaba leaf is obtained by adding about 10 times the amount of solvent to banaba leaf, attaching a reflux condenser, and heating to 35 to 45 ° C on a water bath. Is the way.
- the low-temperature extraction method is a method obtained by, for example, adding a solvent to banaba leaves and immersing them in 15 to 25 for 2 to 3 days.
- the extraction solvents include ethanol, 1,3-butylene glycol, ethyl acetate, hexane, ether, acetone, methanol, 1-propanol, 2-propanol, 1-butanol, and 2-butanol in addition to water.
- examples thereof include organic solvents such as knol, glycerin, and polyethylenedaricol, and these can be used alone or as a mixture of two or more. Among them, water, ethanol, and a mixture thereof are preferably used.
- the oral composition of the present invention may be used in combination with at least two or more types of extract obtained by the above extraction method.
- Banana leaves, soil thorns, and river water having a darcosyltransferase inhibitory action can be used.
- the dosage form of the oral composition of the present invention is not particularly limited, such as a solid preparation, a semi-solid preparation, a liquid preparation, and the like.
- chewing gum, candy, troche, mouth freshener, mouthwash, toothpaste And the like foods, pharmaceuticals, and quasi-drugs.
- a chewing gum can be mixed with a gum base such as a vegetable resin, a vinyl acetate resin, or an ester gum, sugar, starch syrup, a fragrance, and a softener.
- Candies can contain dairy products, starch, flour, fats and oils, acidulants, coagulants, food colors, flavors, fruits, seeds and the like.
- the lozenges may contain sugar, starch syrup, acid, fragrance and the like.
- abrasives such as calcium hydrogen phosphate and calcium carbonate, wetting agents such as glycerin and sorbitol, surfactants such as sodium lauryl sulfate, sweeteners, flavors, carboxymethyl cellulose, sodium alginate, and carrageenan.
- Thickeners such as nan and methylcellulose can be added.
- bactericides such as cetylpyridinium chloride, chlorhexidine salt, benzalkonium chloride, and benzotonium chloride
- dodecyltrimethylammonium bromide tetradodecyltrimethylammonium bromide
- decalinium chloride odor
- a cationic fungicide such as domiphen chloride.
- the content of at least one extract of the present invention selected from the group consisting of banaba leaf, dorsal bark, river rind bark, potato bark, fir ginseng, white pepper, black pepper, small pepper, and wu li, It is appropriately prepared depending on the type and the like and is not particularly limited.
- the dry solid content is usually 0.01 to 5% by mass, preferably 0.05 to 2% by mass in the case of nava leaves with respect to the total amount of the composition.
- it is usually 0.01 to 5% by mass, preferably 0.05 to 2% by mass.
- Kawasaki bark it is usually 0.01 to 5% by mass, preferably 0.05 to 2% by mass.
- the amount is usually 0.02 to 5% by mass, preferably 0.08 to 3% by mass.
- the amount is usually 0.02 to 5% by mass, preferably 0.08 to 3% by mass.
- white pepper it is usually 0.05 to 5%, preferably 0.1 to 2%.
- Production Example 1 (50% ethanol extract of banaba leaf) 50 g of ethanol extract of banaba leaf was put into a 500 ml bottle of 50 g of dry powder, 250 ml of 50% ethanol was added, and the mixture was shaken for 10 minutes. Suction filtration was performed using a filter paper to obtain a leachate. Further, the exudate was concentrated under reduced pressure and freeze-dried to obtain an extract of banaba leaf extract of Production Example 1.
- Production Example 2 Water extract of banaba leaf
- the water extract of banaba leaf was prepared by adding 50 g of dry ground powder into a 500 ml bottle, adding purified water 2 50 ml, and allowing to stand all day. Suction filtration was performed using a filter paper to obtain a leachate. Further, the exudate was freeze-dried to obtain an extract of Banana leaf extract of Production Example 2.
- Production Example 5 50% ethanol extract of Kawasaki bark is prepared by adding 50 g of dried and ground powder of Kawasaki bark to a 500 ml bottle and adding 25% Oml of 50% ethanol for 10 minutes. Shake. Filtration was performed using a filter paper to obtain a leachate. Further, the leachate was concentrated under reduced pressure and freeze-dried to obtain an extract of Kawasaki bark in Production Example 5.
- Preparation Example 6 (50% ethanol extract of potato) The 50% ethanol extract of potato is prepared by adding 5 Og of dried powder of potato into a 500 ml bottle, adding 25 Oml of 50% ethanol, Shake for minutes. Suction filtration was performed using a filter paper to obtain a leachate. Further, the leachate was concentrated under reduced pressure and freeze-dried to obtain a potato extract extract of Production Example 6.
- Production Example 7 (50% ethanol extract of ginseng) A 50% ethanol extract of feng ginseng was obtained by adding 5 Og of dried powdered ginseng to a 500 ml bottle, adding 25 Oml of 50% ethanol, and shaking for 10 minutes. Suction filtration was performed using a filter paper to obtain a leachate. Further, the leachate was concentrated under reduced pressure and freeze-dried to obtain an extract of Chinese ginseng of Production Example 7.
- Production Example 8 (50% Ethanol Extract of White Pepper) A 50% ethanol extract of white pepper is obtained by drying 50 g of dried and ground powder of white pepper to 50 Om 9427
- Production Example 9 (50% Ethanol Extract of Black Pepper) For a 50% ethanol extract of black pepper, 50 g of dried and ground powder of black pepper was placed in a 500 ml bottle, 25 Oml of 50% ethanol was added, and the mixture was shaken for 10 minutes. Filtration was performed using a filter paper to obtain a leachate. Further, the leachate was concentrated under reduced pressure and freeze-dried to obtain an extract of black pepper of Production Example 9.
- Production Example 10 (50% Ethanol Extract of Shoji) A 50% ethanol extract of Shoji was prepared by adding 5 Og of dried and ground powder of Shoji into a 500 ml bottle, adding 25 Oml of 50% ethanol, and shaking for 10 minutes. Suction filtration was performed using filter paper to obtain a leachate. Further, the leachate was concentrated under reduced pressure and freeze-dried to obtain an extract of Koujimi of Production Example 10.
- Test Example 1 (Darcosyltransferase inhibitory action) (1) Test method
- Test results Table 1 shows the results of Test 1. As is evident from Table 1, the extract of banaba leaf, soil thorn bark, kawaji bark, potato, and ginseng showed strong darcosyltransferase inhibitory activity.
- Test Example 2 (Darcosyltransferase inhibitory action) (1) Test method The extract used in Examples 1, 4, 7, and 10 described below in place of the extract of banapa leaf, dorsal bark, river rind, potato, and ginseng used in Test Example 1 The test was carried out in the same manner as in Test Example 1 except that was used.
- Test results Table 2 shows the results of Test 2. As is clear from Table 2, the product containing the extract of banaba leaf showed a strong inhibitory activity against darcosyltransferase.
- Test Example 3 (P. gingivalis-derived collagenase inhibitory action) (1) Test method
- MMP_1 active type I collagenase; Kagay Central Research Institute
- Collagenase inhibitory activity ((F 0 -F) ZF.) X 100 (%)
- F Fluorescence intensity when the sample was added
- F Q Fluorescence intensity when the sample was not added
- IC 50 value The sample concentration (igZml) at which the inhibition rate became 50% was determined and defined as IC 50 value.
- Table 3 shows the results of Test 3. As is clear from Table 3, the extract of banaba leaf showed strong collagenase inhibitory activity. Table 3 Inhibition of collagenase by banaba leaf 50% ethanol extract
- Test Example 4 (P. Growth inhibitory action) (1) Test method The extracted extracts obtained in Production Examples 8 to 11 have final concentrations of 12.5, 25, 50, 100, and 200 Mg / m1. the variant was added to GAM agar medium, pre 5 mg / 1 to Min and 0.5 mg / l Soi bean menadione was added casein Daiji Est culture locations anaerobically at precultured 10 6 CFU / m 1 of P. gingivalis ( Porphyromonas gingival is) ATC C 33277 was smeared on the surface and anaerobically cultured at 37 ° C for 3 days. The minimum concentration of the extract in which the bacteria did not grow on the modified GAM agar medium to which the extract having the above concentration was added was defined as the minimum inhibitory concentration (MIC).
- MIC minimum inhibitory concentration
- Table 4 shows the results of Test 4. As is clear from Table 4, each extract had strong P. gingivalis growth inhibitory activity. Table 4
- Examples of oral compositions according to the present invention in various dosage forms are described below.
- Examples 1-3 Chewing gum was produced according to the following formulation (Examples 1-3). (Production method)
- the gum base and starch syrup kept at 40 ° C were put into a double-armed mixer (kneader) and kneaded for 5 minutes. Next, 1/3 amount of sucrose and glucose were added and kneaded for 5 minutes, and 1Z3 amount of sucrose was added to the kneaded material and kneaded for another 5 minutes.
- the extracted extract of banaba leaf, clay thorn, or white pepper and the remaining sucrose were added to a kneaded material, which was previously mixed, and kneaded for 5 minutes to obtain chewing gums of Examples 1 to 3.
- Example 1 (Formulation) Unit parts by mass Banana leaf extract (Production example 1) 0.1 Gum base 20.0 Sucrose 49.9 Glucose 20.0
- Non-sugar chewing gum was produced according to the following formulation (Examples 4 to 7). (Production method)
- the gum base and multi-l syrup kept at 40 ° C were put into a double-armed mixer (21-D) and kneaded for 5 minutes. Next, 1Z3 amount of xylitol and maltitol were added and kneaded for 5 minutes, and 1Z3 amount of xylitol and maltitol were added to the kneaded material and further kneaded for 5 minutes. Pour into a kneaded mixture of pre-mixed extract of Banana leaf, Kawasaki bark, or black pepper and the remaining xylitol and maltitol, and knead for 5 minutes to obtain non-sugar chewing gum of Examples 4 to 7. Was.
- Example 4 (Formulation) Unit: parts by mass Banana leaf extract (Preparation Example 1) 0.1 Gum base 20.0 Xylil 19.9 4 Multi 1 ⁇ 1 20.0 Maltitol syrup 10.0
- Example 5 (Formulation) Unit: parts by mass Extract from Kawahibari (Preparation Example 5) 1.0 Gum base 20.0 Xylitol 49.0 Maltitol 20.0 Multi 1, 1 syrup 10.0
- Example 8 (Mouthwash) A mouthwash was manufactured according to the following formulation (Examples 8 to 11).
- Example 12 The following recipe was produced (production method)
- Example 12 After cooling, the candy of Example 12 was obtained.
- Example 12 (Formulation) Unit: parts by mass Banana leaf extract (Preparation Example 1) 0.5 Granulated sugar 60.0 Ginger syrup 39.9 Purified water
- Examples 13 to 16 Toothpaste was manufactured according to the following formulation (Examples 13 to 16). (Manufacturing method) The components from the extract of banaba leaf, fir ginseng, or Wuyi to the purified water were mixed and stirred by a mixer equipped with stirring blades to obtain toothpastes of Examples 13 to 16.
- Example 13 (Formulation) Unit: parts by mass Banana leaf extract (Preparation Example 1) 0.1 Sodium carboxymethylcellulose 1.0 Glycerin 4.0 Sorbi! ⁇ 29.0 Calcium phosphate 36.9 Calcium carbonate 10.0 Caic anhydride 3.0 Sodium lauryl sulfate 0.5 Xylitol 8.0 Purified water 7.5
- the oral composition of the present invention exhibits an excellent darcosyltransferase inhibitory action, collagenase inhibitory action, or P. gingivalis growth inhibitory action. Therefore, the oral composition of the present invention is useful for preventing caries and periodontal disease.
- the darcosyltransferase inhibitor, collagenase inhibitor and P. gingivalis growth inhibitor of the present invention comprise, as an active ingredient, at least one selected from the above-mentioned extracts, and use two or more of them. Is also good.
- At least one extracted extract selected from the group consisting of banaba leaf, earthen bark, river bark, potato bark, potato, and ginseng having a darcosyltransferase inhibitory activity, and a periodontopathogenic bacterium Borfuiromonas gingivalis ( (Porphyromonas gingival is)
- the use of at least one extract selected from the group consisting of white pepper, black pepper, small jelly, and Wuyi, which have a growth-inhibiting effect increases the preventive effect of caries or periodontal disease. Because it is preferred.
- the darcosyltransferase inhibitor, the collagenase inhibitor, and the P are preferred.
- gingivalis growth inhibitor of the present invention may be any other known or future-known darcosyltransferase inhibitors, as long as they do not interfere with the effects of the present invention. It can also be combined with components such as a collagenase inhibitor and a P. gingivalis growth inhibitor. Further, the darcosyltransferase inhibitor, collagenase inhibitor and P-gingivalis growth inhibitor of the present invention may be used in combination with a component usually contained in the oral composition according to the type of the oral composition to be applied. can do.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003252683A AU2003252683A1 (en) | 2002-08-02 | 2003-07-25 | Composition for oral use |
JP2004537533A JPWO2004026273A1 (ja) | 2002-08-02 | 2003-07-25 | 口腔用組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002225663 | 2002-08-02 | ||
JP2002-225663 | 2002-08-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004026273A1 true WO2004026273A1 (ja) | 2004-04-01 |
Family
ID=32013231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/009427 WO2004026273A1 (ja) | 2002-08-02 | 2003-07-25 | 口腔用組成物 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2004026273A1 (ja) |
AU (1) | AU2003252683A1 (ja) |
WO (1) | WO2004026273A1 (ja) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006219441A (ja) * | 2005-02-14 | 2006-08-24 | Kuraray Family Seihin Kk | 齲蝕または歯周病予防剤 |
JP2006306832A (ja) * | 2005-03-31 | 2006-11-09 | Kobayashi Pharmaceut Co Ltd | 歯肉上皮細胞伸展阻害剤 |
JP2007186457A (ja) * | 2006-01-13 | 2007-07-26 | Ichimaru Pharcos Co Ltd | トリプターゼ活性阻害剤およびその利用 |
JP2007238485A (ja) * | 2006-03-07 | 2007-09-20 | Lotte Holdings Ltd | メチオニナーゼ阻害剤及びそれを含有する口腔用組成物並びに飲食品 |
JP2011079754A (ja) * | 2009-10-05 | 2011-04-21 | Kao Corp | セラミド産生促進剤及び保湿剤 |
CN102327328A (zh) * | 2011-09-28 | 2012-01-25 | 广东紫金正天药业有限公司 | 含有拳参的组合物及其用途 |
JP2013010715A (ja) * | 2011-06-29 | 2013-01-17 | Nippon Flour Mills Co Ltd | う蝕予防剤、歯周病予防剤及び口腔用組成物 |
JP2014129305A (ja) * | 2012-12-28 | 2014-07-10 | Kao Corp | 歯磨組成物 |
CN104524115A (zh) * | 2015-01-21 | 2015-04-22 | 柏跃龙 | 一种治疗牙周炎的中药制剂 |
KR101517095B1 (ko) * | 2014-12-03 | 2015-05-04 | 주식회사 제이앤케이 글로벌리소스 | 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 |
US9445987B2 (en) | 2009-10-05 | 2016-09-20 | Kao Corporation | Ceramide production enhancer and moisturizer |
JP2017205067A (ja) * | 2016-05-19 | 2017-11-24 | 江崎グリコ株式会社 | 口腔用組成物及びその製造方法 |
JP2018104376A (ja) * | 2016-12-27 | 2018-07-05 | サンスター株式会社 | 歯磨組成物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5855409A (ja) * | 1981-09-28 | 1983-04-01 | Lion Corp | 歯周疾患予防及び治療用組成物 |
EP0452273A1 (en) * | 1990-04-12 | 1991-10-16 | Warner-Lambert Company | Combination of formate esters and pepper-like constituents as an orally-consumable chloroform substitute |
EP1161944A1 (en) * | 1999-01-29 | 2001-12-12 | Sunstar Inc. | Drugs, foods and oral compositions containing stilbene-type compounds |
JP2003119117A (ja) * | 2001-10-15 | 2003-04-23 | Maruzen Pharmaceut Co Ltd | 抗う蝕剤及び口腔用組成物 |
-
2003
- 2003-07-25 JP JP2004537533A patent/JPWO2004026273A1/ja active Pending
- 2003-07-25 WO PCT/JP2003/009427 patent/WO2004026273A1/ja active Application Filing
- 2003-07-25 AU AU2003252683A patent/AU2003252683A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5855409A (ja) * | 1981-09-28 | 1983-04-01 | Lion Corp | 歯周疾患予防及び治療用組成物 |
EP0452273A1 (en) * | 1990-04-12 | 1991-10-16 | Warner-Lambert Company | Combination of formate esters and pepper-like constituents as an orally-consumable chloroform substitute |
EP1161944A1 (en) * | 1999-01-29 | 2001-12-12 | Sunstar Inc. | Drugs, foods and oral compositions containing stilbene-type compounds |
JP2003119117A (ja) * | 2001-10-15 | 2003-04-23 | Maruzen Pharmaceut Co Ltd | 抗う蝕剤及び口腔用組成物 |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006219441A (ja) * | 2005-02-14 | 2006-08-24 | Kuraray Family Seihin Kk | 齲蝕または歯周病予防剤 |
JP2006306832A (ja) * | 2005-03-31 | 2006-11-09 | Kobayashi Pharmaceut Co Ltd | 歯肉上皮細胞伸展阻害剤 |
JP2007186457A (ja) * | 2006-01-13 | 2007-07-26 | Ichimaru Pharcos Co Ltd | トリプターゼ活性阻害剤およびその利用 |
JP2007238485A (ja) * | 2006-03-07 | 2007-09-20 | Lotte Holdings Ltd | メチオニナーゼ阻害剤及びそれを含有する口腔用組成物並びに飲食品 |
US9445987B2 (en) | 2009-10-05 | 2016-09-20 | Kao Corporation | Ceramide production enhancer and moisturizer |
JP2011079754A (ja) * | 2009-10-05 | 2011-04-21 | Kao Corp | セラミド産生促進剤及び保湿剤 |
US9682029B2 (en) | 2009-10-05 | 2017-06-20 | Kao Corporation | Ceramide production enhancer and moisturizer |
JP2013010715A (ja) * | 2011-06-29 | 2013-01-17 | Nippon Flour Mills Co Ltd | う蝕予防剤、歯周病予防剤及び口腔用組成物 |
CN102327328A (zh) * | 2011-09-28 | 2012-01-25 | 广东紫金正天药业有限公司 | 含有拳参的组合物及其用途 |
JP2014129305A (ja) * | 2012-12-28 | 2014-07-10 | Kao Corp | 歯磨組成物 |
KR101517095B1 (ko) * | 2014-12-03 | 2015-05-04 | 주식회사 제이앤케이 글로벌리소스 | 천연 추출물을 이용한 치주질환 치료 및 예방용 조성물 |
CN104524115A (zh) * | 2015-01-21 | 2015-04-22 | 柏跃龙 | 一种治疗牙周炎的中药制剂 |
JP2017205067A (ja) * | 2016-05-19 | 2017-11-24 | 江崎グリコ株式会社 | 口腔用組成物及びその製造方法 |
JP2018104376A (ja) * | 2016-12-27 | 2018-07-05 | サンスター株式会社 | 歯磨組成物 |
Also Published As
Publication number | Publication date |
---|---|
AU2003252683A1 (en) | 2004-04-08 |
AU2003252683A8 (en) | 2004-04-08 |
JPWO2004026273A1 (ja) | 2006-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007001961A (ja) | 抗菌剤及びそれを含む口腔用組成物並びに飲食品 | |
JP4948044B2 (ja) | プラーク形成抑制剤、または抗う蝕菌剤 | |
JP4112730B2 (ja) | 口腔用抗菌剤 | |
WO2004026273A1 (ja) | 口腔用組成物 | |
KR100821694B1 (ko) | 치근막 보호제 | |
JP4630416B2 (ja) | 坑う蝕、歯周病剤 | |
JPWO2003099304A1 (ja) | 抗歯周病菌組成物、該抗歯周病菌組成物を含有する抗歯周病用飲食物及び口腔用洗浄剤 | |
WO2007020830A1 (ja) | 口腔用組成物 | |
JPH04164021A (ja) | 口腔用組成物 | |
WO2022075481A1 (ja) | サツマイモ由来のイモ蜜又はイモ蜜の上清を含有する口腔ケア組成物 | |
JP2005035907A (ja) | 抗歯周病剤 | |
JPWO2004096165A1 (ja) | エナメル質脱灰抑制素材 | |
WO2021033661A1 (ja) | 歯肉上皮細胞活性化剤 | |
JP4633399B2 (ja) | グルコシルトランスフェラーゼ阻害剤 | |
KR102540804B1 (ko) | 비자나무 추출물을 포함하는 미생물의 바이오필름 형성 억제용 조성물 | |
JP2001089386A (ja) | 抗う蝕剤 | |
JP4585066B2 (ja) | う蝕防止剤、口腔用剤および飲食物 | |
JP2005035909A (ja) | 抗歯周病剤 | |
JP5361354B2 (ja) | 苦味が軽減されたマビンロウ抽出物の製造方法及び該方法により製造されたマビンロウ抽出物 | |
JPH0413630A (ja) | う蝕防止剤 | |
JP3472172B2 (ja) | 口腔用剤 | |
JP2005035908A (ja) | 抗歯周病剤 | |
KR102115575B1 (ko) | 개똥쑥과 죽염을 포함하는 구강질환 예방 또는 치료용 조성물 | |
JP6918529B2 (ja) | 口腔用組成物 | |
KR20230046792A (ko) | 호초 추출물을 포함하는 바이오필름 형성 억제용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2004537533 Country of ref document: JP |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |